Literature DB >> 31166814

Leucine-rich repeat kinase 2 regulates mouse dendritic cell migration by ORAI2.

Jing Yan1,2, Wenhui Zhao3, Chao Gao1,2, Xia Liu1,2, Xiuliang Zhao1,2, Ting Wei1,2, Zhaodi Gao1,2.   

Abstract

The leucine-rich repeat kinase 2 (LRRK2) is expressed in various immune cells and involved in regulating inflammatory processes. LRRK2 facilitates calcium extrusion exchanger and sodium-calcium exchanger activity and hence influences intracellular Ca2+ concentration in dendritic cells (DCs). DC maturation and migration are governed by the intracellular Ca2+ concentration, but the related mechanisms whereby LRRK2 regulates DC function and involved Ca2+ channels are still under investigation. In the previous study, we found that LRRK2-/- DCs exhibited higher store-operated Ca2+ entry (SOCE) activity than LRRK2+/+ DCs. Herein, we ascertained the exact SOCE components by using genetic, pharmacological, and fluorescent approaches. Ca2+ imaging showed that LRRK2 kinase activity negatively modulated SOCE activity. Moreover, LRRK2 deficiency resulted in an enhanced migration capacity of DCs but had little effect on the maturation process. SOCE is widely known to regulate DC functions; we wanted to dissect the reason why LRRK2 specifically influenced DC migration and therefore silenced ORAI1, ORAI2, and ORAI3, respectively. Transwell assays showed that both ORAI1 and ORAI2 silencing markedly decreased the migration of DCs, but only ORAI1 deficiency influenced the expression of maturation markers CD11c, CD86, and major histocompatibility complex class II. Of note, LRRK2 deficiency increased ORAI2 expression but not that of ORAI1 and ORAI3. Thus, we suggest that LRRK2 modulates DC migration by interfering with ORAI2.-Yan, J., Zhao, W., Gao, C., Liu, X., Zhao, X., Wei, T., Gao, Z. Leucine-rich repeat kinase 2 regulates mouse dendritic cell migration by ORAI2.

Entities:  

Keywords:  Ca signaling; DC; SOCE; sodium-calcium exchanger

Mesh:

Substances:

Year:  2019        PMID: 31166814     DOI: 10.1096/fj.201802550R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  4 in total

Review 1.  The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson's Disease.

Authors:  Mengfei Zhang; Chaoyi Li; Jie Ren; Huakun Wang; Fang Yi; Junjiao Wu; Yu Tang
Journal:  Front Aging Neurosci       Date:  2022-05-11       Impact factor: 5.702

2.  ORAI2 Down-Regulation Potentiates SOCE and Decreases Aβ42 Accumulation in Human Neuroglioma Cells.

Authors:  Elena Scremin; Mario Agostini; Alessandro Leparulo; Tullio Pozzan; Elisa Greotti; Cristina Fasolato
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

Review 3.  Immune Response Modifications in the Genetic Forms of Parkinson's Disease: What Do We Know?

Authors:  Luca Magistrelli; Elena Contaldi; Francesca Vignaroli; Silvia Gallo; Federico Colombatto; Roberto Cantello; Cristoforo Comi
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

4.  Increased long noncoding RNA LINK-A contributes to rheumatoid synovial inflammation and aggression.

Authors:  Jingnan Wang; Chuyu Shen; Ruiru Li; Cuicui Wang; Youjun Xiao; Yu Kuang; Minxi Lao; Siqi Xu; Maohua Shi; Xiaoyan Cai; Liuqin Liang; Hanshi Xu
Journal:  JCI Insight       Date:  2021-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.